Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02663518
Title A Trial of TTI-621 for Patients With Hematologic Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Trillium Therapeutics Inc.
Indications

hematologic cancer

lymphoma

Therapies

TTI-621

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.